« Back
Home /
Azithromycin (hydrate)

Azithromycin (hydrate)

Item no.	HY-17506A-10mM
Manufacturer	MedChem Express
CASRN	117772-70-0
Amount	10 mM/1 mL
Quantity options	100 mg 10 mM/1 mL 1 ea 200 mg 500 mg 50 mg
Category	Neuroscience Neuroinflammation Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.0
Citations	[1]Menzel M, et al. Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation. Oncotarget. 2017 Mar 18.\|[2]Vandooren J, et al. Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study. PLoS One. 2017 Apr 3;12(4):e0174853. Mol Ther. 2022 Feb 18;S1525-0016(22)00102-2.\|ACS Chem Biol. 2021 Dec 15.\|ACS Infect Dis. 2024 Apr 12;10(4):1327-1338.\|ACS Omega. March 3, 2022.\|Acta Pharm Sin B. 2021 Mar 11.\|Adv Sci (Weinh). 2020 Jul 21;7(17):2001374.\|Biochem Biophys Res Commun. 2020 Feb 19;522(4):862-868.\|Biochem Pharmacol. 2021 Sep 30;114793.\|bioRxiv. 2021 Jan 19.\|bioRxiv. 2024 Apr 4.\|bioRxiv. 2024 May 10.\|Cell Rep. 2023 Dec 12;42(12):113563.\|COVID. 2021, 1(1), 263-275.\|Emerg Microbes Infect. 2024 Dec;13(1):2321981.\|Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep.\|Immunol Invest. 2025 Jan 9:1-13.\|Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):33.\|iScience. 5 January 2022, 103731.\|Journal of Pharmaceutical Research International. 33(47B): 274-279, 2021.\|Katedra farmakologie a toxikologie. 2020 Jul.\|Nano Today. 2025 Apr.\|Patent. US20200101105A1.\|Pathogens. 2024 Nov 15;13(11):1003.\|PLoS Pathog. 2024 Nov 5;20(11):e1012614.\|Research Square Preprint. 2022 Jun.\|Theranostics. 2022 Jan 1;12(3):1187-1203.\|Viruses. 2019 Nov 15;11(11):1064.\|Viruses. 2020 Jun 10;12(6):628.
Smiles	C[C@@H]([C@@H]([C@@](C(O[C@@H]([C@@](C)(O)[C@@H]1O)CC)=O)([H])C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)[C@H]([C@](O)(C[C@H](CN([C@@H]1C)C)C)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O.O.O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CP-62993 dihydrate
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-anti-virus
Manufacturer - Targets	Antibiotic; Autophagy; Bacterial; Parasite
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, protect from light, stored under nitrogen)
Molecular Weight	785.02
Product Description	Azithromycin hydrate is a macrolide antibiotic useful for the treatment of a number of bacterial infections.
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection; Autophagy
Isoform	Macrolide
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-17506A-10mM-safety-datasheet.pdf